在乳腺癌中新的HER-2向疗法
Catarina Lopes Fernandes1, Diogo J Silva1, Alexandra Mesquita1,2
1Medical Oncology Department, Pedro Hispano Hospital, 4464-513 Matosinhos, Portugal.
Cancers
|January 11, 2024
概括
针对人类表皮生长因子2 (HER-2) 阳性乳腺癌的新疗法显著提高了存活率. 本综述涵盖了已批准的治疗方法和新兴的HER-2导向药物,用于HER-2-阳性和HER-2-低乳腺癌.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 遗传学 遗传学 是一个
背景情况:
- 人类表皮生长因子2 (HER-2) 阳性乳腺癌是一种具有不良预后的侵袭性亚型.
- 针对HER-2的疗法彻底改变了治疗方法,改善了生存率和生活质量.
- 最近的进展包括治疗HER-2-低乳腺癌的疗法,扩大治疗选择.
研究的目的:
- 要总结最近批准的治疗策略,用于HER-2-阳性乳腺癌.
- 审查正在开发中的新型和实验性HER-2向疗法.
- 为了突出治疗HER-2-阳性和HER-2-低乳腺癌的进展.
主要方法:
- 最近的临床试验和监管批准的文献审查.
- 分析新兴的治疗目标和药物开发管道.
- 综合关于生存益处和治疗疗效的数据.
主要成果:
- 几种新的HER-2向疗法已经获得批准,证明了显著的生存益处.
- 目前正在进行的研究正在探索针对HER-2-阳性和HER-2-低乳腺癌的新药和组合.
- 针对HER-2的治疗环境正在迅速发展,有望出现新的治疗方法.
结论:
- 已批准的HER-2向疗法显著改善了HER-2-阳性乳腺癌患者的治疗结果.
- 针对HER-2导向疗法的开发管道是强大的,提供未来的治疗进展.
- 对这些疗法的 HER-2-低乳腺癌反应的认识扩大了它们的临床影响.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
01:27Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:30Cancer Vaccines
368
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
368
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K